NewsTuesday, 19. December 2006
Gilead Announces Preliminary Results From Phase III Study
PARI’s eFlow Wins Good Design Award
MONTEREY, CALIFORNIA, January 3, 2007 – PARI’s eFlow was awarded a 2006 GOOD DESIGN Award for medical equipment by The Chicago Athenaeum: Museum of Architecture and Design earlier this month. This is the second design award eFlow has won this year, following the Medical Design Excellence Award granted in April. eFlow is a handheld, electronic nebulizer that dramatically reduces treatment time for aerosolized medications targeting the lungs.
“We are extremely pleased to be recognized by the design community for the modern styling of eFlow. In addition to vastly improving the technology so that patients have faster inhaled medication therapies, we spent a lot of time on the look and feel. eFlow is light, fits in the palm of your hand, and is very comfortable and easy to use. These awards are icing on the cake, and they show that quality and design go hand in hand,” said Thomas Gallem, Head of Product Design at PARI.
eFlow uses a perforated, vibrating membrane that enables extremely efficient aerosolization of liquid medications. Compared to other nebulizer systems, eFlow can produce aerosols with a very high density of active drug, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size, light weight, and battery use, eFlow helps reduce the burden of taking daily inhaled treatments.
Due to its efficiency, eFlow is licensed to pharmaceutical companies during drug development and for later commercialization, so that drug and device are optimized together for the final product. This customization is currently being utilized in the development of new and improved treatments for cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD), alpha-1-antitrypsin deficiency, lung transplant rejection, respiratory syncytial virus infection (RSV), and for systemic drug delivery via the lungs.
eFlow was developed by PARI and incorporates TouchSpray Technology licensed from the Technology Partnership, Cambridge, UK. eFlow’s modern, sleek shape was designed by Eckstein Design in Munich, Germany. Eckstein designs medical equipment, consumer, and industrial goods and has also designed PARI’s portable and desktop compressor/nebulizer systems.
About GOOD DESIGN Awards
Founded in Chicago in 1950 by architects Eero Saarinen, Charles and Ray Eames, and Edgar Kaufmann, Jr., the GOOD DESIGN Awards bestow international recognition upon the world’s most prominent designers and manufacturers for advancing innovative product concepts and for stretching the envelope beyond what is considered basic product design. GOOD DESIGN is organized by The Chicago Athenaeum: Museum of Architecture and Design. Additional information online at www.chi-athenaeum.org.
PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's primary focus is to provide patients with innovative products and services that help control disease. PARI also develops pharmaceutical drug products for pulmonary and nasal administration as liquid aerosols and already has several clinical development programs ongoing, either partnered or on its own. PARI is headquartered in Starnberg, Germany, with a major presence in the United States and offices in Japan, United Kingdom, Russia, and China.
Additional information on eFlow is available by contacting Kirsten Ayars at 805-452-7909 or Geoff Hunziker at